A directory that helps people find addiction and mental-health treatment, monetised the way Google is — facilities pay to be on the first page — went from $300K of annual recurring revenue in 2017 to over $30M, financed almost entirely with revenue-based debt instead of equity
about $4.5M of revenue-based debt deployed across the relationship, drawn in escalating tranches as it grew · one small Series A of $5M in 2024, described as small relative to ARR · revenue model is advertiser-funded placement paid by treatment facilities, explicitly not subscription software
Fewer bars = easier, cheaper, or faster for an AI-assisted solo builder. Editorial judgments based on the case details.
This case comes secondhand, from the VP of Sales at Lighter Capital — the lender that has financed the company since 2017 — rather than from the founders, so read it as a lender's account of a portfolio company. What he describes: Recovery.com helps people who need either addiction care or mental-health care find the right facility for them. When Lighter first lent to them in 2017 they were doing about $300,000 in annual recurring revenue, and he calls the facility they extended "a really small" one. Lighter then kept growing the facility as the company grew, deploying roughly $4.5 million in total across the relationship in escalating tranches. At the time of the interview the company was over $30 million in annual recurring revenue. Along the way it raised a Series A of $5 million in 2024, which the lender pointedly describes as small relative to its ARR. He raises the company specifically as his counter-example to the idea that a lender needs a clean B2B SaaS contract to underwrite: "absolutely not a pure B2B SaaS model," and financed for eight years anyway. Our read: the arc here — $300K to $30M+ over roughly eight years, roughly a hundredfold, financed with about $4.5M of debt and a single small equity round — is one of the most capital-efficient growth curves in this directory, and it happened in a category most builders would dismiss as a lead-gen site.
5 more sections — the full story, the playbook, the risks, and the numbers. Free account unlocks everything.
Create free accountEmail code only. No password.The quick-reference card — acquisition channels, replication playbook, and risk map — unlocks with a free account.
Create free accountEmail code only. No password.Paste into Claude Code / Codex and get a working version of this product end-to-end.
Two production-grade prompts per idea: a full build spec and an SEO growth plan. Copy, paste, ship.
Go Pro — $10/moCancel anytime.Every claim traces back to a source video.
Source video links unlock with a free account. Full transcripts are Pro.
Create free accountEmail code only. No password.Data credibility: Second-hand and sponsored. Every figure comes from Tanner Kavassovich, VP of Sales at Lighter Capital, describing a portfolio client on a podcast episode that the show openly identifies as sponsored by Lighter Capital. No founder of Recovery.com speaks, no dashboard, screenshot or third-party data is shown, and the lender has a commercial interest in the story sounding good. Lender-reported and unaudited: $300K ARR at first funding in 2017, over $30M ARR at the time of the interview, about $4.5M of debt deployed across the relationship, and a $5M Series A in 2024 described as small relative to ARR. The revenue model — treatment facilities paying for first-page placement, "kind of like Google" — is his one-sentence characterisation, not a documented pricing structure; no rate card, advertiser count, traffic figure, margin, headcount or profitability is given anywhere. ⚠️ The transcript never states the company's country or city. Because the surrounding conversation is US-centric (US dollars, US lending norms, another portfolio company identified as Utah-based) it is tempting to assume the United States, but that is inference about the lender rather than a statement about this company, so we have left the region field null. Everything in this entry beyond the one-line business description and the stated figures is our own analysis and is marked as such.